BRIGHTCOVE(NASDAQ:BCOV) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to BCOV. BCOV was compared to 82 industry peers in the IT Services industry. While BCOV seems to be doing ok healthwise, there are quite some concerns on its profitability. BCOV is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BCOV was profitable.

BCOV had a positive operating cash flow in the past year.

BCOV had negative earnings in 4 of the past 5 years.

In the past 5 years BCOV always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.34%, BCOV is in line with its industry, outperforming 40.51% of the companies in the same industry.

BCOV has a Return On Equity (-9.58%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-4.34%
ROE	-9.58%
ROIC	N/A

ROA(3y)-4.02%

ROA(5y)-5.56%

ROE(3y)-9.19%

ROE(5y)-12.88%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 61.60%, BCOV belongs to the top of the industry, outperforming 81.01% of the companies in the same industry.

In the last couple of years the Gross Margin of BCOV has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for BCOV so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	61.6%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.06%

GM growth 5Y0.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BCOV has been increased compared to 1 year ago.

BCOV has more shares outstanding than it did 5 years ago.

There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.08, we must say that BCOV is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of BCOV (0.08) is worse than 84.81% of its industry peers.

BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	0.08

ROIC/WACCN/A

WACC10.83%

2.3 Liquidity

A Current Ratio of 0.75 indicates that BCOV may have some problems paying its short term obligations.

With a Current ratio value of 0.75, BCOV is not doing good in the industry: 88.61% of the companies in the same industry are doing better.

A Quick Ratio of 0.75 indicates that BCOV may have some problems paying its short term obligations.

BCOV has a Quick ratio of 0.75. This is amonst the worse of the industry: BCOV underperforms 88.61% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.75
Quick Ratio	0.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.45% over the past year.

BCOV shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.

Measured over the past years, BCOV shows a small growth in Revenue. The Revenue has been growing by 4.07% on average per year.

EPS 1Y (TTM)145.45%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

Revenue 1Y (TTM)-0.22%

Revenue growth 3Y0.64%

Revenue growth 5Y4.07%

Sales Q2Q%-2.02%

3.2 Future

Based on estimates for the next years, BCOV will show a very strong growth in Earnings Per Share. The EPS will grow by 64.74% on average per year.

Based on estimates for the next years, BCOV will show a small growth in Revenue. The Revenue will grow by 0.01% on average per year.

EPS Next Y100%

EPS Next 2Y64.74%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-1.51%

Revenue Next 2Y0.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 89.00, the valuation of BCOV can be described as expensive.

Compared to the rest of the industry, the Price/Earnings ratio of BCOV is on the same level as its industry peers.

BCOV's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.39.

BCOV is valuated quite expensively with a Price/Forward Earnings ratio of 124.65.

The rest of the industry has a similar Price/Forward Earnings ratio as BCOV.

BCOV is valuated rather expensively when we compare the Price/Forward Earnings ratio to 94.38, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	89
Fwd PE	124.65

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BCOV is on the same level as its industry peers.

BCOV's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	51.96
EV/EBITDA	23.8

4.3 Compensation for Growth

BCOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as BCOV's earnings are expected to grow with 64.74% in the coming years.

PEG (NY)0.89

PEG (5Y)N/A

EPS Next 2Y64.74%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BCOV!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BRIGHTCOVE

NASDAQ:BCOV (2/3/2025, 8:15:51 PM)

After market: 4.45 0 (0%)

4.45

+0.01 (+0.23%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustryIT Services

Earnings (Last)11-04 2024-11-04/amc

Earnings (Next)02-12 2025-02-12/amc

Inst Owners70.58%

Inst Owner Change-47.89%

Ins Owners5.23%

Ins Owner Change-166.23%

Market Cap201.05M

Analysts45.71

Price Target4.54 (2.02%)

Short Float %0.48%

Short Ratio0.31

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)100%

Min EPS beat(2)56.43%

Max EPS beat(2)143.57%

EPS beat(4)4

Avg EPS beat(4)114.38%

Min EPS beat(4)56.43%

Max EPS beat(4)161.44%

EPS beat(8)6

Avg EPS beat(8)77.66%

EPS beat(12)10

Avg EPS beat(12)100.79%

EPS beat(16)14

Avg EPS beat(16)114.38%

Revenue beat(2)2

Avg Revenue beat(2)0.71%

Min Revenue beat(2)0.56%

Max Revenue beat(2)0.87%

Revenue beat(4)2

Avg Revenue beat(4)-0.15%

Min Revenue beat(4)-1.91%

Max Revenue beat(4)0.87%

Revenue beat(8)2

Avg Revenue beat(8)-1%

Revenue beat(12)6

Avg Revenue beat(12)-0.14%

Revenue beat(16)10

Avg Revenue beat(16)0.35%

PT rev (1m)0%

PT rev (3m)14.84%

EPS NQ rev (1m)0%

EPS NQ rev (3m)50%

EPS NY rev (1m)N/A

EPS NY rev (3m)100%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-0.39%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0.25%

Valuation

		Industry Rank	Sector Rank
PE	89
Fwd PE	124.65
P/S	1.01
P/FCF	51.96
P/OCF	14.73
P/B	2.11
P/tB	11.84
EV/EBITDA	23.8

EPS(TTM)0.05

EY1.12%

EPS(NY)0.04

Fwd EY0.8%

FCF(TTM)0.09

FCFY1.92%

OCF(TTM)0.3

OCFY6.79%

SpS4.42

BVpS2.11

TBVpS0.38

PEG (NY)0.89

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.34%
ROE	-9.58%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	61.6%
FCFM	1.94%

ROA(3y)-4.02%

ROA(5y)-5.56%

ROE(3y)-9.19%

ROE(5y)-12.88%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.06%

GM growth 5Y0.65%

F-Score7

Asset Turnover0.95

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	50.16%
Cap/Sales	4.89%
Interest Coverage	N/A
Cash Conversion	186.6%
Profit Quality	N/A
Current Ratio	0.75
Quick Ratio	0.75
Altman-Z	0.08

F-Score7

WACC10.83%

ROIC/WACCN/A

Cap/Depr(3y)143.44%

Cap/Depr(5y)123.4%

Cap/Sales(3y)7.87%

Cap/Sales(5y)6.39%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)145.45%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-60%

EPS Next Y100%

EPS Next 2Y64.74%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.22%

Revenue growth 3Y0.64%

Revenue growth 5Y4.07%

Sales Q2Q%-2.02%

Revenue Next Year-1.51%

Revenue Next 2Y0.01%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y51.3%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year979.3%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y4.57%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-44.43%

OCF growth 3Y-40.43%

OCF growth 5Y12.05%

BRIGHTCOVE (BCOV) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens